ABSTRACT
tor antibodies, and thyroid echographic pattern were considered. Results: Autoimmune thyroid disease was found in 90 of 343 (26.2%) patients with CD (62 on a gluten-free diet) and in 20 (10%) of the control subjects (P ‫ס‬ 0.001). Fifty-four (15.7%) patients with CD and autoimmune markers had normal thyroid function (euthyroidism) as did 12 (6.0%) of the control subjects; hypothyroidism was observed in 28 (8.1%) patients with CD and in 7 (3.5%) of the control subjects. Hyperthyroidism was diagnosed in four patients with CD and in none of the control subjects with autoimmune markers. An abnormal echographic pattern was seen in 37 patients with CD (16.8%) and only in 1 (1.6%) of the control subjects (P ‫ס‬ 0.002).
Conclusions:
The high frequency of autoimmune thyroid disease found among patients with CD, even those on a gluten-free diet, may justify a thyroid status assessment at diagnosis and at follow-up evaluation of children with CD. Several studies (1, 2) have reported an association between celiac disease (CD) and other autoimmune disorders. In prospective studies of adults with CD, autoimmune thyroid disease was observed in 14% (3) and 30.3% (4) of patients.
In prospective studies, thyroid abnormalities were described in 37.6% (5) and 41.1% (6) of pediatric patients with CD. Noteworthy was the presence of high titers of serum antithyroperoxidase antibodies in 14.4% (7) and serum antithyroglobulin antibodies in 52.6% (8) of the untreated pediatric patients, which was reported to return to normal in treated patients after 2 or 3 years on a gluten-free diet (GFD). This finding suggests that these antibodies are gluten dependent.
The aim of this study was to establish the prevalence of autoimmune thyroid involvement in a large group of untreated and treated pediatric patients with CD. Therefore, a large multicenter study was performed under the auspices of the Italian "Club del Tenue" on a large Italian patient population from Torino, Bologna, Foggia, Rome (two clinics), Naples, and Bari. Thyroid involvement was evaluated and correlated to CD status.
PATIENTS AND METHODS
Three hundred forty-three biopsy-proven CD patients, aged 9 months to 18 years (median age, 8.5 years; 230 girls and 113 boys), were observed between January 1997 and December 2000 at 7 participating outpatient CD clinics participating in the study. Two hundred fifty-six of the patients, aged 17 months to 18 years (median age, 9 years; 179 girls and 77 boys), had been following a GFD for months or years (range, 3 months to 16 years), and 87 were untreated (51 girls, 36 boys; aged 9 months to 18 years; median, 6.2 years). The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) criteria (9) were used for diagnosis.
Two hundred thirty control subjects, aged 8 months to 17.3 years (median age, 8.3 years; 122 girls, 108 boys), were randomly selected from pediatric patients resident in the areas of study and examined at the same outpatient clinics from which the patients were recruited. All control subjects were examined for gastrointestinal disorders and had no known immunologic disorder. Informed consent was requested and obtained from parents and/or patients.
Demographic (age and gender), clinical (compliance to GFD; when pertinent, signs of thyroid disease), serologic (thyroid function tests and thyroid-specific antibodies), and instrumental (echographic examination of the thyroid) data were collected for each patient and control subject at enrollment.
Serum free triiodothyronine (FT3), free thyroxine (FT4), and thyroid-stimulating hormone (TSH) were detected by radioimmunoassay (RIA) using commercial kits (normal values, 3-15.3 pg/mL for FT4; 2.6-5.8 pg/mL for FT3; 0.2-0.4 (U/mL for TSH). Thyroid-specific antibody titles were also detected using competitive RIA with coated-tube technique thyroperoxidase antibodies (AbTPO; normal values <100 U/mL), RIAimmunoradiometric assay (IRMA) with solid-phase technique antithyroglobulin (AbHTG; normal values <50 U/mL), and RIA with anti-TSH receptor (TBIAb; normal values <10 U/mL).
Thyroid Disease Classification
A diagnosis of autoimmune thyroid disease was made when AbTPO was more than 100 U/mL antibody titles associated with an abnormal echographic pattern, AbTPO was more than 800 U/mL, AbHTG was more than 50 U/mL, or when antibodies and/or abnormal echographic pattern were present.
Thyroid function was classified using the American Thyroid Association guidelines (10) . Overt hyperthyroidism was noted by a decrease in TSH serum levels and an increase of FT4; subclinical hyperthyroidism was indicated by a decrease of TSH serum levels and normal FT4; overt hypothyroidism was demonstrated by an increase in TSH serum concentration and a significant decrease in FT4 serum levels; and subclinical hypothyroidism was noted by an increase in TSH serum concentration and normal FT4. The prevalence of autoimmune thyroid disease is 2.5 times higher in celiac patients (26.2%) than in controls (10.0%) Chi square ‫ס‬ 20.403 (1 df) P ‫ס‬ 0.001.
Echographic images were graded for thyroid disease according to Sostre at al. (11) and Marcocci et al. (12) . Four patterns were identified and graded.
• Grade 1 (G1): diffusely enlarged gland with a normoechoic sonographic pattern • Grade 2 (G2): multiple hypoechoic or patches scattered through an otherwise normoechoic gland, a pattern suggesting focal rather than diffuse involvement • Grade 3 (G3): enlarged gland with diffuse but mild hypoechogenicity • Grade 4 (G4): enlarged gland with diffuse and marked hypoechogenicity
Thyroid-specific antibodies were available for all patients with CD (343) and for 199 of 230 control subjects (86.5%). The thyroid hormones and the TSH were evaluated in all but 12 patients with CD (3.4%) and were not evaluated in 13 of the control subjects (5.6%). Only patients with complete data were included in the percentage calculated.
Statistical Analyses
The study enrolled 343 patients with CD and 230 control subjects, numbers sufficient to appreciate a 2.5 prevalence ratio assuming a 10% CD prevalence of thyroid disorders in the control group and accepting a power of 0.80 and a 0.05 onesided type first error. The 2 test was used when appropriate to test differences between patients and control subjects. Poisson distribution was used for calculation of the 95% confidence interval (CI) of prevalence data. For all hypotheses tested, twotailed P values less than 0.05 were considered significant. Table 1 shows the sex and ages of the 343 patients with CD, according to CD status and duration of the GFD. Table 2 shows the thyroid involvement for all subjects (CD patients and controls) included in the study and the CD status for patients with CD.
RESULTS
There were no serologic signs of autoimmune disease in 253 patients with CD (194 were on a GFD). Hypothyroidism was observed in 16 (4.7%) patients with CD and in 24 (12.0%) of the control subjects.
Serologic signs of autoimmune disease were found in 90 (26.2%) patients with CD and in 20 (10.0%) of the control subjects with significant differences between the two groups ( 2 ‫ס‬ 20.403 [1 df]; P ‫ס‬ 0.001). The prevalence of autoimmune thyroid disease was 2.5-fold higher in patients with CD than in control subjects. Thirty-seven patients with CD tested positive for AbTPO; 53 were positive for AbHTG; and 25 of the 90 were positive for both. Euthyroidism was observed in 54 of 90 (15.7%) patients (39 on a GFD). Hypothyroidism was observed in 28 (8.1%) patients with CD (19 on a GFD) and in 7 (3.5%) control subjects. Hyperthyroidism was diagnosed in four (1.2%) patients with CD on a GFD and in none of the control subjects. Table 3 shows the prevalence of thyroid disease classes in patients with CD on a GFD, in untreated patients, and in control subjects (all patients were included, i.e., those with or without autoimmune thyroid disease).
Three patients with CD and autoimmune thyroid disease and on a GFD had overt hypothyroidism, and four similar patients had hyperthyroidism; all were started on an appropriate medical treatment.
Echographic examination, performed in 220 patients with CD and in 61 of the control subjects, showed an abnormal pattern in 37 patients with CD and in 1 of the control subjects ( 2 ‫ס‬ 9.409 [1 df]; P ‫ס‬ 0.002; Table 4 ). Varying severity in echographic pattern in the autoimmune patients with CD was seen in 22 euthyroid patients, 11 hypothyroid patients, and in all hyperthyroid patients (Table 5 ).
DISCUSSION
Our data are representative of the Italian pediatric population because a large number of subjects were ex- Although many of the patients with CD observed in this study had been on a GFD for a long time, they still developed autoimmune thyroid impairment, suggesting that gluten withdrawal did not protect them. On the contrary, the decrease of the thyroid antibodies after 2 or 3 years (7, 8) or the normalization of thyroid function (4) after 1 year of GFD has been reported in other studies. These different results may depend on longer duration of GFD in our treated patients with CD.
The prevalence of autoimmune thyroid impairment in our patients with CD is higher than that obtained by Ventura et al. (7) using AbTPO, and lower than the data obtained by Forchielli et al.(5) , Kowalska et al. (6) , and Toscano et al. (8) . The difference between our results and those of other studies (5-8) may be because we determined more than one antibody and we enrolled a larger series of patients with CD, respectively.
The thyroid antibodies were positive in some of our euthyroid patients with CD. Therefore, even if the clinical significance of these antibodies in patients with CD has not yet been clarified, the results suggest that there may be a higher propensity for thyroid involvement. In most patients, the immune response to the target cell destroys the endocrine gland progressively, leading to hypofunction. Thus, a longitudinal follow-up study of euthyroid patients with positive autoimmune thyroid serology would be advisable to establish whether these findings should be considered only an epiphenomenon or if they could be of prognostic help.
There were no serologic signs of autoimmune disease in the hypothyroidism observed in 16 patients with CD and in 24 control subjects; this finding could be attributed to a decreased thyroid hormone synthesis induced by either an iodine organification defect or a functional hypothalamic-pituitary disturbance.
An abnormal ultrasound thyroid pattern, characterized by diffuse hypoechogenicity, has been reported in patients with autoimmune thyroid disease. Reduced thyroid echogenicity is found in patients with diffuse lymphocytic thyroiditis and is often associated with, or may predict, autoimmune hypothyroidism (12) . Nevertheless, some of our patients with diffuse thyroid hypoechogenicity had normal thyroid function.
In conclusion, the present study shows an increased prevalence of serologic and/or echographic evidence of thyroid autoimmunity among our pediatric patients with CD, regardless of their CD status. A high frequency of autoimmune thyroid disease was found among patients with CD, even in those on a GFD, and may justify a thyroid status assessment at diagnosis and at follow-up evaluation of children with CD. A longitudinal follow-up evaluation of our patients with CD would seem advisable to understand the impact of gluten withdrawal on the evolution of autoimmune thyroid disease. 
